Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKinsey
Novartis
Federal Trade Commission
Fish and Richardson
Moodys
Harvard Business School
QuintilesIMS
Farmers Insurance
Teva

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077394

« Back to Dashboard

NDA 077394 describes SODIUM BICARBONATE, which is a drug marketed by Hospira, Hospira Inc, Intl Medication Sys, and Abbott, and is included in eight NDAs. It is available from five suppliers. Additional details are available on the SODIUM BICARBONATE profile page.

The generic ingredient in SODIUM BICARBONATE is sodium bicarbonate. There are one thousand four hundred and fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sodium bicarbonate profile page.
Summary for 077394
Tradename:SODIUM BICARBONATE
Applicant:Hospira
Ingredient:sodium bicarbonate
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 077394
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM BICARBONATE sodium bicarbonate INJECTABLE;INJECTION 077394 ANDA Hospira, Inc. 0409-3486 0409-3486-16 10 CARTON in 1 CONTAINER (0409-3486-16) > 1 SYRINGE, PLASTIC in 1 CARTON > 50 mL in 1 SYRINGE, PLASTIC
SODIUM BICARBONATE sodium bicarbonate INJECTABLE;INJECTION 077394 ANDA Hospira, Inc. 0409-3495 0409-3495-16 10 CARTON in 1 CONTAINER (0409-3495-16) > 1 SYRINGE, PLASTIC in 1 CARTON > 50 mL in 1 SYRINGE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.9MEQ/ML
Approval Date:Nov 9, 2005TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MEQ/ML
Approval Date:Nov 9, 2005TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Teva
Baxter
Fuji
Deloitte
Dow
QuintilesIMS
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot